Comparison of the Analgesic Effects of Continuous Versus Single-Shot Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery
1 other identifier
interventional
90
1 country
1
Brief Summary
Patients undergoing arthroscopic shoulder surgery often experience moderate to severe postoperative pain. Various medical treatments are employed to provide analgesia for these patients. The advancement of regional anesthesia techniques has made possible to both reduce the use of narcotic analgesics and provide long-term pain management benefits. The Serratus Posterior Superior Intercostal Plane Block (SPSIPB) was first described in 2023 by Serkan Tulgar et al. Cadaveric studies and dermatomal analyses in patients have demonstrated its ability to provide analgesia in the back, neck, shoulder, axilla, and lateral thoracic regions. Even though patients undergoing shoulder surgery benefit from the block; once the duration of a single-shot block wears off, they may experience severe pain again. The aim of this study is to investigate the analgesic effects of a single-shot SPSIPB compared to continuous infusion provided by placing a catheter in this region. The hypothesis of this study: In arthroscopic shoulder surgery, the continuous application of the serratus posterior superior intercostal plane block using a catheter will result in lower pain scores, reduced opioid consumption, and improved patient satisfaction compared to single-shot application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
February 14, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2025
CompletedJanuary 2, 2026
February 1, 2025
7 months
February 10, 2025
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Opioid Consumption
Patient-Controlled Analgesia (Tramadol)
Postoperative 24 hours
Secondary Outcomes (5)
Postoperative Pain Scores
Postoperative 24 hours
Patient Satisfaction (Likert scale)
Post surgery 24 hours
Postoperative Nausea and Vomiting Scale
24 hours
Perioperative Remifentanyl Consumption
Perioperative assessment
Use of Rescue Analgesics in the Ward
24 hours
Study Arms (3)
Group 1: This patient group will not undergo any regional block
NO INTERVENTIONGroup 2: Patients who will receive a single-shot serratus posterior superior plane block
ACTIVE COMPARATORGroup 3: Patients who will receive a continuous SPSIB with catheter
ACTIVE COMPARATORInterventions
30 mL of 0.25% bupivacaine will be injected as single-shot block 20 mins prior to surgery
In addition to administration of 30 mL of 0.25% bupivacaine prior to surgery, a catheter will be placed in the area to administer bolus of 1 mg/kg of 0.25% bupivacaine every 8 hours postoperatively.
Eligibility Criteria
You may qualify if:
- Aged between 18-80 years
- No bleeding diathesis
- Classified as ASA I-II-III
You may not qualify if:
- Patients who do not provide consent
- Patients with coagulopathy
- History of allergy or intoxication to local anesthetic agents
- Patients with advanced organ failure
- History of neuropathic disease
- Patients with mental retardation
- Presence of infection at the injection site
- Conditions in which regional anesthesia is contraindicated
- Pediatric patients and those over 80 years of age
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Goztepe Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Senem Koruk
Goztepe Prof Dr Suleyman Yalcın City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Resident, M.D.
Study Record Dates
First Submitted
February 10, 2025
First Posted
February 14, 2025
Study Start
March 1, 2025
Primary Completion
September 15, 2025
Study Completion
October 10, 2025
Last Updated
January 2, 2026
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share